Technology has been used to either inform or expedite the prescribing process in most modern healthcare systems for over two decades. Recently, market forces - including greater regulatory intervention, increased investment from stakeholders and decreased resistance from end-users - have begun to converge to set the stage for widespread adoption of truly integrated ePrescribing solutions.
Presenting the eHealthInsight series report: ePrescribing - Infrastructure and Impact on the Healthcare Markets in the US and EU, which details recent trends in the arena of electronic prescriptions. Produced by Datamonitor and distributed by ePharmaceuticals™, a division of HCPro, Inc., this report includes topics such as: pros and cons of ePrescribing, barriers to adoption by physicians and consumers, opportunities for pharmaceutical companies to maintain a presence in the decision-making process, and more.
Key reasons to read this report
- Identify the dangers of the traditional paper-based prescribing model and how electronic prescribing can improve patient safety and compliance
- Understand the importance of developing electronic medical records in parallel with ePrescribing initiatives
- Assess opportunities for pharmaceutical companies to maintain a share-of-voice during the prescribing process
Scope of the report
- Insight into the different approaches taken towards adoption of ePrescribing in the US and the EU
- Identification of current drivers of adoption and why they are important to the success of ePrescribing long-term
- Analysis of physicians' and consumers' views on ePrescribing and how they are affecting the rate of adoption in the US and EU
- Recommendations for the pharmaceutical industry as to how to retain a share-of-voice in adoption, particularly with regard to designing functional standards
Report highlights
One of the greatest challenges facing ePrescribing has been finding a balance between the wants and needs of industry and end-users. Several stakeholders have been vying for influence over the design and implementation of ePrescribing systems. While this has served to move the market forward, considerable conflicts of interest have also emerged.
The attitude of the physician towards ePrescribing is the most important consideration for stakeholders because it is the point at which adoption either stalls or moves forward. Historically, physicians have been offered a variety of reasons and incentives to adopt ePrescribing, with varying degrees of success.
It is the pharmaceutical industry's responsibility to ensure that decisions made at the point of care are not unduly controlled by other stakeholders, such as disruptive messaging meant to influence a physician to continuously second-guess specific prescribing decisions, or inequitable screen displays, which give preference to certain treatments.
The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/437-4276 or e-mail epharm@hcpro.com
Save money when you purchase multiple copies! Ask your customer service representative about money-saving
discounts and bulk orders. Call toll free 800-650-6787 or e-mail
customerservice@hcpro.com.
